{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:17:47Z","timestamp":1780420667078,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.intimp.2019.106068","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T19:21:14Z","timestamp":1576005674000},"page":"106068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response"],"prefix":"10.1016","volume":"78","author":[{"given":"Alshimaa","family":"Aboalsoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah H.","family":"El-Ghaiesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur F.","family":"Abd Elmonem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed L.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Abdel Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.106068_b0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0006-8993(91)90909-F","article-title":"Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization","volume":"551","author":"Zagon","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2019.106068_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ar.a.20161","article-title":"Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium","volume":"282","author":"Zagon","year":"2005","journal-title":"Anatomical Record Part A Discoveries Mol. Cell. Evolut. Biol."},{"key":"10.1016\/j.intimp.2019.106068_b0015","first-page":"R1094","article-title":"Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis","volume":"272","author":"Zagon","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.intimp.2019.106068_b0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3181\/0901-RM-16","article-title":"Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation","volume":"234","author":"Cheng","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2019.106068_b0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:CANC.0000031773.46458.63","article-title":"Opioid peptides in cancer","volume":"23","author":"Fichna","year":"2004","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.intimp.2019.106068_b0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bcp.2012.05.018","article-title":"The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease","volume":"84","author":"McLaughlin","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2019.106068_b0035","doi-asserted-by":"crossref","first-page":"R774","DOI":"10.1152\/ajpregu.00318.2010","article-title":"Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation","volume":"299","author":"Cheng","year":"2010","journal-title":"Am. J. Physiol. Regulat. Integrat. Comparat. Physiol."},{"key":"10.1016\/j.intimp.2019.106068_b0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(92)91542-M","article-title":"Ontogeny of zeta (zeta), the opioid growth factor receptor, in the rat brain","volume":"596","author":"Zagon","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2019.106068_b0045","first-page":"991","article-title":"Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor","volume":"14","author":"McLaughlin","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2019.106068_b0050","doi-asserted-by":"crossref","first-page":"R1716","DOI":"10.1152\/ajpregu.00075.2009","article-title":"Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis","volume":"296","author":"Donahue","year":"2009","journal-title":"Am. J. Physiol. Regulat. Integrat. Comparat. Physiol."},{"key":"10.1016\/j.intimp.2019.106068_b0055","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"key":"10.1016\/j.intimp.2019.106068_b0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/1-4020-3764-3_9","article-title":"DNA replication and genomic instability","volume":"570","author":"Zhu","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2019.106068_b0065","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2019.106068_b0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1258\/ebm.2011.011121","article-title":"Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model","volume":"236","author":"Donahue","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2019.106068_b0075","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.intimp.2013.10.012","article-title":"Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)","volume":"17","author":"Meng","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.106068_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3835(96)04119-5","article-title":"Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone","volume":"101","author":"Hytrek","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2019.106068_b0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1258\/ebm.2011.011096","article-title":"Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin","volume":"236","author":"Donahue","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2019.106068_b0090","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/S0022-5347(05)68157-8","article-title":"Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor","volume":"162","author":"Bisignani","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2019.106068_b0095","first-page":"577","article-title":"Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor","volume":"14","author":"Zagon","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2019.106068_b0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","article-title":"Low-dose naltrexone for disease prevention and quality of life","volume":"72","author":"Brown","year":"2009","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.intimp.2019.106068_b0105","first-page":"189","article-title":"Synergistic effect of aged garlic extract and naltrexone on improving immune responses to experimentally induced fibrosarcoma tumor in BALB\/c mice","volume":"5","author":"Ebrahimpour","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.intimp.2019.106068_b0110","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-gamma in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin. Cancer Res.: Off. J. Am. Associat. Cancer Res."},{"key":"10.1016\/j.intimp.2019.106068_b0115","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2019.106068_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/jir.2009.0008","article-title":"Opioid-like activity of naltrexone on natural killer cell cytolytic activity and cytokine production in splenocytes: effects of alcohol","volume":"30","author":"Boyadjieva","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.intimp.2019.106068_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/989163","article-title":"Effect of honey and eugenol on Ehrlich ascites and solid carcinoma","volume":"2010","author":"Jaganathan","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2019.106068_b0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4067\/S0716-97602003000200015","article-title":"Antitumor activities of iodoacetate and dimethylsulphoxide against solid Ehrlich carcinoma growth in mice","volume":"36","author":"Fahim","year":"2003","journal-title":"Biol. Res."},{"key":"10.1016\/j.intimp.2019.106068_b0135","article-title":"Lithium modulates autophagy in esophageal and colorectal cancer cells and enhances the efficacy of therapeutic agents in vitro and in vivo","volume":"10","author":"O'Donovan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.106068_b0140","first-page":"1787","article-title":"Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus","volume":"26","author":"Attia","year":"1966","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2019.106068_b0145","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1093\/ilar.53.1.55","article-title":"Mice anesthesia, analgesia, and care, Part I: anesthetic considerations in preclinical research","volume":"53","author":"Gargiulo","year":"2012","journal-title":"ILAR J."},{"key":"10.1016\/j.intimp.2019.106068_b0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1440-1681.2007.04601.x","article-title":"Optimizing dosage of ketamine and xylazine in murine echocardiography","volume":"34","author":"Xu","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106068_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0301s39","article-title":"Isolation of mouse mononuclear cells","volume":"39","author":"Kruisbeek","year":"2000","journal-title":"Current Protocols Immunol."},{"key":"10.1016\/j.intimp.2019.106068_b0160","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3892\/or.2013.2279","article-title":"Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation","volume":"29","author":"Astolfi","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2019.106068_b0165","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","article-title":"Murine models to evaluate novel and conventional therapeutic strategies for cancer","volume":"170","author":"Talmadge","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2019.106068_b0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0006-8993(93)91355-V","article-title":"Zeta (zeta), the opioid growth factor receptor: identification and characterization of binding subunits","volume":"605","author":"Zagon","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2019.106068_b0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ygyno.2011.04.009","article-title":"The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice","volume":"122","author":"Donahue","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.intimp.2019.106068_b0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-2478(00)00208-X","article-title":"Ehrlich ascites tumour unbalances splenic cell populations and reduces responsiveness of T cells to Staphylococcus aureus enterotoxin B stimulation","volume":"74","author":"Segura","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2019.106068_b0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.106068_b0190","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","article-title":"Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells","volume":"166","author":"Gabrilovich","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.106068_b0195","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","article-title":"5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity","volume":"70","author":"Vincent","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2019.106068_b0200","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.106068_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111960","article-title":"Magnetite nanoparticles inhibit tumor growth and upregulate the expression of p53\/p16 in Ehrlich solid carcinoma bearing mice","volume":"9","author":"Bassiony","year":"2014","journal-title":"PLoS One"},{"issue":"29\u201349","key":"10.1016\/j.intimp.2019.106068_b0210","first-page":"2013","article-title":"Anti tumor effect of chitosan and silibinin and their combination in mice bearing Ehrlich ascites tumors : Impact of p53 and p21","volume":"15","author":"Yousra","year":"2013","journal-title":"Biol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919317382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919317382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:15:08Z","timestamp":1761585308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919317382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":42,"alternative-id":["S1567576919317382"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106068","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106068"}}